Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Alecensa
Active Ingredient: Alectinib hydrochloride 161.33mg equivalent to alectinib 150mg
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Excella GmbH & Co KG, Feucht, Germany
   
Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Manufacturing Belgium NV, Puurs, Belgium
   
Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Pfizer Manufacturing Belgium NV, Puurs, Belgium
Note: This is for the application received 27 August 2019. 
   
Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Pfizer Manufacturing Belgium NV, Puurs, Belgium
Note: This is for the application received 10 September 2019. 
   
Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Pfizer Manufacturing Belgium NV, Puurs, Belgium
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany


Dated this 2nd day of June 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).